Please login to the form below

Not currently logged in
Email:
Password:

Synovate Healthcare appoints Paul Villa

Synovate Healthcare has appointed Paul Villa as senior vice president of payer and market access research for specialist healthcare research

Synovate Healthcare, the global specialist healthcare market research arm of Synovate, has appointed Paul Villa to the role of senior vice president of payer and market access research for its specialist healthcare research division.

Villa joins from global research-based consultancy firm Genactis, where he held the role of vice president responsible for leading US pricing and reimbursement projects. Villa brings vast knowledge of the US payer market to Synovate Healthcare, along with detailed knowledge of multiple therapy areas. He also has experience in the commercialisation and pricing of products in managed markets, which he gained in a previous marketing consultancy role.

Bob Douglas, global head of Synovate Healthcare said: "Paul's hands-on professional style and extensive and varied experience both agency and client-side make him a valuable addition to our team. I look forward to working with Paul to grow our payer research capabilities both in the US and globally."

Villa will lead a dedicated payer and market access research team and will take responsibility for delivering research-based guidance to clients on market access issues.


19th October 2010

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics